Caseware UK (AP4) 2024.0.164 2024.0.164 true0true02024-01-01falseNo description of principal activityfalse 04201938 2024-01-01 2024-12-31 04201938 2023-01-01 2023-12-31 04201938 2024-12-31 04201938 2023-12-31 04201938 c:Director5 2024-01-01 2024-12-31 04201938 d:CurrentFinancialInstruments 2024-12-31 04201938 d:CurrentFinancialInstruments 2023-12-31 04201938 d:CurrentFinancialInstruments d:WithinOneYear 2024-12-31 04201938 d:CurrentFinancialInstruments d:WithinOneYear 2023-12-31 04201938 d:ShareCapital 2024-12-31 04201938 d:ShareCapital 2023-12-31 04201938 d:OtherMiscellaneousReserve 2024-12-31 04201938 d:OtherMiscellaneousReserve 2023-12-31 04201938 d:RetainedEarningsAccumulatedLosses 2024-12-31 04201938 d:RetainedEarningsAccumulatedLosses 2023-12-31 04201938 c:FRS102 2024-01-01 2024-12-31 04201938 c:Audited 2024-01-01 2024-12-31 04201938 c:FullAccounts 2024-01-01 2024-12-31 04201938 c:PrivateLimitedCompanyLtd 2024-01-01 2024-12-31 04201938 c:SmallCompaniesRegimeForAccounts 2024-01-01 2024-12-31 04201938 2 2024-01-01 2024-12-31 04201938 e:PoundSterling 2024-01-01 2024-12-31 iso4217:GBP xbrli:pure


















BRE-BMR CITP (Cambridge) Limited
























Financial statements



For the year ended 31 December 2024



Registered number: 04201938

 
BRE-BMR CITP (Cambridge) Limited - Registered number: 04201938



Statement of financial position
As at 31 December 2024

2024
2023
Note
£
£

  

Current assets
  

Debtors
 4 
123,270,467
123,328,097

Bank and cash balances
  
41
7,765

  
123,270,508
123,335,862

Creditors: amounts falling due within one year
 5 
(42,274,917)
(42,366,962)

Net current assets
  
 
 
80,995,591
 
 
80,968,900

Total assets less current liabilities
  
80,995,591
80,968,900

  

Net assets
  
80,995,591
80,968,900


Capital and reserves
  

Called up share capital 
  
1
1

Capital contributions
  
1,082,824
1,082,824

Profit and loss account
  
79,912,766
79,886,075

  
80,995,591
80,968,900


The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The company has opted not to file the statement of comprehensive income in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf by: 




Orestis Tzortzoglou
Director

Date: 22 September 2025

The notes on pages 2 to 3 form part of these financial statements.

Page 1

 
BRE-BMR CITP (Cambridge) Limited


Notes to the financial statements
For the year ended 31 December 2024

1.


General information

BRE-BMR CITP (Cambridge) Limited is a private company limited by shares and is incorporated in England and Wales. The registered office of the company is C/O Buzzacott LLP, 130 Wood Street, London, EC2V 6DL and the principal place of business is The McClintock Building, Granta Park, Great Abington, Cambridge, CB21 6GP. The registered number is 04201938.

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with FRS 102 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland' and the requirements of the Companies Act 2006. The disclosure requirements of Section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The following principal accounting policies have been applied:

 
2.2

Going concern

The directors have received assurance from BRE-BMR CITP Holdco Limited that it will provide continuing financial support to the company sufficient to allow it to continue trading for the foreseeable future. On this basis, the directors consider it appropriate to prepare the financial statements on a going concern basis.
However, should this support be withdrawn or future funding not be available, the going concern basis used
in preparing the company's financial statements may be invalid and adjustments would have to be made to
reduce the value of the assets to their realisable amount and to provide for any further liabilities that might
arise. The financial statements do not include any adjustment to the company's assets or liabilities that might
be necessary should the going concern basis not continue to be appropriate.

 
2.3

Foreign currency translation

Functional and presentation currency

The company's functional and presentational currency is GBP.

Transactions and balances

Foreign currency transactions are translated into the functional currency using the spot exchange rates at the dates of the transactions.

At each period end foreign currency monetary items are translated using the closing rate. Non-monetary items measured at historical cost are translated using the exchange rate at the date of the transaction and non-monetary items measured at fair value are measured using the exchange rate when fair value was determined.

 
2.4

Interest income

Interest income is recognised in profit or loss using the effective interest method.

 
2.5

Debtors

Short-term debtors are measured at transaction price, less any impairment. 

Page 2

 
BRE-BMR CITP (Cambridge) Limited
 

Notes to the financial statements
For the year ended 31 December 2024

2.Accounting policies (continued)

 
2.6

Creditors

Short-term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.


3.


Employees

The average monthly number of employees during the year was 0 (2023 - 0).
The directors are not considered to be employees of the company as they are remunerated through another group company.


4.


Debtors

2024
2023
£
£


Amounts owed by group undertakings
123,265,087
122,372,053

Other debtors
5,380
956,044

123,270,467
123,328,097



5.


Creditors: amounts falling due within one year

2024
2023
£
£

Amounts owed to group undertakings
42,117,320
42,197,793

Accruals and deferred income
157,597
169,169

42,274,917
42,366,962



6.


Inclusion in consolidated financial statements

BioMed Realty, L.P. is the parent company of the smallest group of which the company is a member
and for which group financial statements are prepared. The registered office of BioMed Realty, L.P. is
7 St. Paul Street, Suite 820, Baltimore MD, 21202, United States of America.


7.


Auditor's information

The auditor's report on the financial statements for the year ended 31 December 2024 was unqualified.

The audit report was signed on 24 September 2025 by Thomas Allison (Senior statutory auditor) on behalf of Buzzacott Audit LLP.

Page 3